Janelle Bradley

News

Study Findings Show Considerable Disease Burden of NF1-PN Among Affected Patients

07/01/2024

Findings from the real-world CASSIOPEA study show the considerable disease burden of neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN) highlighting the importance of effective treatments for this patient population.

Findings from the real-world...

07/01/2024

Oncology

News

Vinblastine/Methotrexate Fails to Demonstrate Activity for NF1-PN in Pediatric and Young-Adult Patients

07/01/2024

Janelle Bradley ;

Findings from a phase 2 study show vinblastine/methotrexate did not demonstrate activity for neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN) in pediatric and young-adult patients, despite being well-tolerated.

Findings from a phase 2 study...

07/01/2024

Oncology

News

07/01/2024

Janelle Bradley ;

Study findings show neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN) worsens adult patient and caregiver health-related quality of life vs that of the general population.

Study findings show...

07/01/2024

Oncology

News

Selumetinib for Managing NF1-PN in Pediatric Patients at Risk for Developing Tumor-Related Morbidity

07/01/2024

Janelle Bradley ;

Among pediatric patients with neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN), treatment with selumetinib resulted in significant shrinkage in PN without any clinically significant morbidity.

Among pediatric patients with...

07/01/2024

Oncology